PTI

PTI_News
Coronavirus Jan 26, 2022 - 16:19

Covishield, Covaxin likely to be capped at Rs 275 per dose post regular market approval

According to sources, the National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines affordable.
Covaxin